Results 211 to 220 of about 150,695 (362)

The impact of the dose adjustment for normal eating (DAFNE) structured education programme on health outcomes and healthcare costs for people with type 1 diabetes in Ireland

Diabetic Medicine, Volume 42, Issue 4, April 2025.
Shikha Sharma, Paddy Gillespie, Anna Hobbins, Sean F. Dinneen   +3 more
wiley   +1 more source

The efficacy of intermittent scanning continuous glucose monitoring in the elderly: A case–control study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims The efficacy of intermittently scanning continuous glucose monitoring (is‐CGM) technology among elderly people with diabetes mellitus (DM) has been understudied. We investigated if the initiation of is‐CGM results in improved glycemic control among this population.
Riemer A. Been, Max R. X. van Helsdingen, Darren Zammit, Marco Grzegorczyk, Wim P. Krijnen, Katalin Tamasi, Rijk O. B. Gans, André P. van Beek, Peter R. van Dijk   +8 more
wiley   +1 more source

Antihypertensive Drug Amlodipine Besylate Shows Potential in Alleviating Diabetic Peripheral Neuropathy. [PDF]

Diabetes
Wei Y, Huang Y, Huang R, Ruan Y, Feng T, Zhou F, Zhang W, Lu J, Xie S, Yao Y, Wang J, Ji S, Shen X.   +12 more
europepmc   +1 more source

Sleep impairment in patients with painful diabetic peripheral neuropathy

, 2005
Diane C. Zelman, M. Gore, Nancy A. Brandenburg   +2 more
openalex   +1 more source

Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double‐blind, placebo‐controlled trial [PDF]

, 2010
J. Satoh, Soroku Yagihashi, Masayuki Baba, Makoto Suzuki, Akio Arakawa, Tamotsu Yoshiyama, Satoshi Shoji   +6 more
openalex   +1 more source

Macrovascular and microvascular complications in US Medicare enrollees with type 2 diabetes with and without atherosclerotic cardiovascular disease

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To assess the incidence of macrovascular and microvascular complications in US Medicare enrollees diagnosed with T2D with and without established ASCVD. Materials and Methods We conducted a retrospective cohort study using Medicare fee‐for‐service claims data from 1 January 2006, through 31 December 2021. Baseline demographic and clinical
Tyler J. Dunn, Xi Tan, Joanna Harton, Sonia Kim, Lin Xie, Cory Gamble, Daniel Rotroff   +6 more
wiley   +1 more source

Prevalence and risk factors for painful diabetic peripheral neuropathy: a systematic review and meta-analysis. [PDF]

Front Neurol
Zhou P, Zhou JS, Li JJ, Qin L, Hu WF, Zhang XY, Wang JX, Shi Z.   +7 more
europepmc   +1 more source

PDB41 DIABETIC PERIPHERAL NEUROPATHY: EVALUATION OF THE ASSOCIATION BETWEEN NEUROPATHIC SYMPTOMS (NTSS-6-SA)AND HEALTH CARE RESOURCE USE AND PRODUCTIVE LOSSES

, 2005
CJ Currie, Scott Cawley, CL Morgan, P McEwan, Patricia Price, JR Peters, M Covington   +6 more
openalex   +1 more source

New Therapeutic and Biomarker Discovery for Peripheral Diabetic Neuropathy: PARP Inhibitor, Nitrotyrosine, and Tumor Necrosis Factor-α [PDF]

, 2010
Viktor R. Drel, Sergey Lupachyk, Hanna Shevalye, Іgor Vareniuk, Weizheng Xu, Jie Zhang, Nicholas A. Delamere, Mohammad Shahidullah, Barbara S. Slusher, Irina G. Obrosova   +9 more
openalex   +1 more source

The impact of insulin pump therapy compared to multiple daily injections on complications and mortality in type 1 diabetes: A real‐world retrospective cohort study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Clinical trials have demonstrated the benefits of insulin pump therapy compared with multiple daily injections (MDI) in type 1 diabetes. However, contemporaneous real‐world data are limited. This study investigated the real‐world impact of insulin pump therapy compared with MDI. Materials and Methods A retrospective cohort study of adults
Sophie Haughton, David Riley, Simon Berry, Muhammad Fahad Arshad, Aikaterini Eleftheriadou, Matthew Anson, Yew Wen Yap, Daniel J. Cuthbertson, Rayaz A. Malik, Shazli Azmi, Uazman Alam, Ahmed Iqbal   +11 more
wiley   +1 more source